Beta Bionics, Inc. (BBNX) PT Raised to $21 at TD Cowen
TD Cowen analyst Michael Blackman raised the price target on Beta Bionics, Inc. (NASDAQ: BBNX) to $21.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

